{"id":"CHEMBL103735","canonicalSmiles":"CCCC1(CCC)CCC2(CCN(CCCN(CC)CC)C2)CC1","inchiKey":"SERHTTSLBVGRBY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ATIPRIMOD","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Atiprimod","SKF-106615"],"crossReferences":{"Wikipedia":["Atiprimod"],"drugbank":["DB05513"]},"childChemblIds":["CHEMBL3989809","CHEMBL3215883"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL104","canonicalSmiles":"Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1","inchiKey":"VNFPBHJOKIVQEB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLOTRIMAZOLE","yearOfFirstApproval":1975,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Abtrim","Actavall","Candiden","Canesten","Canesten af","Canesten crm combi","Canesten internal","Canesten vc","Clotrimazole","Fungederm","Gyne-lotrimin","Gyne-lotrimin 3","Gyne-lotrimin 3 combination pack","Gyne-lotrimin combination pack","Gynix","Masnoderm","Mycelex","Mycelex-7","Mycelex-7 combination pack","Mycelex-g","Mycil gold","Privacom","Trimysten","Trivagizole 3"],"synonyms":["BAY 5097","BAY-5097","Clotrimazole","GNF-PF-3499","NSC-257473"],"crossReferences":{"DailyMed":["clotrimazole"],"PubChem":["11110962","11110963","11532882","124879671","144203662","144210733","170464807","26747486","26747487","50106076","50106077","50106078","50106079","569393","85230973","90340692"],"Wikipedia":["Clotrimazole"],"drugbank":["DB00257"],"chEBI":["3764"]},"count":10,"approvedIndications":["EFO_0000544"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1975 and is indicated for infection and has 9 investigational indications."}
{"id":"CHEMBL106502","canonicalSmiles":"COc1ccc(Sc2nc(N)nc3c2ncn3CCOCP(=O)(OCC(F)(F)F)OCC(F)(F)F)cc1","inchiKey":"VDBGPMJFHCJMOL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALAMIFOVIR","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Alamifovir"],"crossReferences":{"drugbank":["DB06368"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1075790","canonicalSmiles":"CO[C@@H]1[C@@H](O)[C@H](C)O[C@@H](O[C@H]2CC[C@]3(C=O)[C@H]4CC[C@]5(C)[C@@H](C6=CC(=O)OC6)CC[C@]5(O)[C@@H]4CC[C@@H]3C2)[C@H]1O","inchiKey":"PMTSPAGBAFCORP-HBUONDEYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PERUVOSIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Peruvoside"],"crossReferences":{"Wikipedia":["Peruvoside"],"drugbank":["DB13756"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1079972","canonicalSmiles":"CSc1ccc(Cl)c(NC(=N)N(C)c2cccc(S[11CH3])c2)c1","inchiKey":"JHVHEDNLONERHY-JVVVGQRLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1079972","maximumClinicalTrialPhase":0,"parentId":"CHEMBL41306","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1088977","canonicalSmiles":"C[S+](CC[C@H](N)C(=O)[O-])C[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O","inchiKey":"MEFKEPWMEQBLKI-AIRLBKTGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ADEMETIONINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Gumbaral","Moodplus","Samyr 200"],"synonyms":["Ademetionine","MSI-195","S-adenosylmethionine","SAM-E","SAME"],"crossReferences":{"drugbank":["DB00118"],"chEBI":["67040"]},"count":5,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL1089641","canonicalSmiles":"Cc1cc(-c2ccc(/N=N/c3c(S(=O)(=O)O)cc4cc(S(=O)(=O)O)cc(N)c4c3O)c(C)c2)ccc1/N=N/c1c(S(=O)(=O)O)cc2cc(S(=O)(=O)O)cc(N)c2c1O","inchiKey":"ZBNARPCCDMHDDV-HVMBLDELSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRYPAN BLUE","yearOfFirstApproval":2004,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Trypan blue"],"crossReferences":{"DailyMed":["trypan%20blue"],"PubChem":["50112808"],"drugbank":["DB09158"],"chEBI":["78900"]},"childChemblIds":["CHEMBL1640"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2004."}
{"id":"CHEMBL1090089","canonicalSmiles":"Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC(CCO)CCO)nc21","inchiKey":"JYYLVUFNAHSSFE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PAMAPIMOD","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pamapimod","R-1503","R1503","RO 4402257","Ro-4402257"],"crossReferences":{"chEBI":["90685"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL1092","canonicalSmiles":"Cl.OC(CCN1CCCCC1)(c1ccccc1)C1CCCCC1","inchiKey":"QDWJJTJNXAKQKD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIHEXYPHENIDYL HYDROCHLORIDE","yearOfFirstApproval":1949,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1490","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Agitane","Artane","Bentex","Broflex","Tremin","Trihexyphenidyl hydrochloride"],"synonyms":["Benzhexol","Trihexyphenidyl HCl","Trihexyphenidyl hydrochloride"],"crossReferences":{"DailyMed":["trihexyphenidyl%20hydrochloride"],"PubChem":["144204826","170464756","26747667","26747668","50107036","50107037","50107038","56422445","855814"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1949."}
{"id":"CHEMBL112570","canonicalSmiles":"CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C","inchiKey":"HVYWMOMLDIMFJA-DPAQBDIFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHOLESTEROL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Cholesterin","Cholesterol","Cholestrin","NSC-8798"],"crossReferences":{"PubChem":["26754461","29215267"],"Wikipedia":["Cholesterol"],"drugbank":["DB04540"],"chEBI":["16113"]},"count":5,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL1160567","canonicalSmiles":"N[C@@H](CCCNC(=O)CP(=O)(O)O)C(=O)O","inchiKey":"FCIHAQFHXJOLIF-YFKPBYRVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1160567","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02011"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1161222","canonicalSmiles":"O=P(O)(O)C(F)(F)c1ccc(CCCCc2ccc(C(F)(F)P(=O)(O)O)cc2)cc1","inchiKey":"SRHSAABKYJDBDV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1161222","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04204"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1162488","canonicalSmiles":"O=C(O)C(=O)Cc1ccccc1","inchiKey":"BTNMPGBKDVTSJY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENYLPYRUVATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Phenylpyruvate"],"crossReferences":{"PubChem":["144211679"],"drugbank":["DB03884"],"chEBI":["30851"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1163070","canonicalSmiles":"Nc1ncnc2c1ncn2[C@@H]1O[C@H](COS(=O)(=O)NC(=O)[C@@H](N)CO)[C@@H](O)[C@H]1O","inchiKey":"HQXFJGONGJPTLZ-YTMOPEAISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Sersa","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Sersa"],"crossReferences":{"drugbank":["DB03869"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1168","canonicalSmiles":"CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1[C@H](C(=O)O)C[C@@H]2CCC[C@@H]21","inchiKey":"HDACQVRGBOVJII-JBDAPHQKSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"RAMIPRIL","yearOfFirstApproval":1991,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Altace","Lopace","Ramipril","Ranace","Tritace"],"synonyms":["C09AA05","HOE 498","HOE-498","Ramipril"],"crossReferences":{"DailyMed":["ramipril"],"PubChem":["144204259","170464731","49664947"],"Wikipedia":["Ramipril"],"drugbank":["DB00178"],"chEBI":["8774"]},"count":23,"approvedIndications":["EFO_0000319","EFO_0000537"],"linkedTargets":{"rows":["ENSG00000159640"],"count":1},"linkedDiseases":{"rows":["EFO_0003086","EFO_0003777","Orphanet_98895","EFO_0000275","EFO_0000401","MONDO_0007254","EFO_0004997","EFO_1001461","MONDO_0002462","EFO_0003913","Orphanet_247","EFO_0003914","MONDO_0001302","EFO_0003911","EFO_0002690","EFO_1001375","EFO_0003144","EFO_0003884","EFO_1002032","EFO_0004285","EFO_0002546","EFO_0000400","EFO_0000685","HP_0003124","EFO_0001645","EFO_0000319","EFO_0004194","EFO_0000537","Orphanet_98896","EFO_0000195","EFO_0000589","MONDO_0100096","EFO_0001359","EFO_0008583","EFO_0000612","EFO_0001360","EFO_0004265"],"count":37},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1991 and is indicated for cardiovascular disease and hypertension and has 21 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL11722","canonicalSmiles":"N[C@@H](CCO)C(=O)O","inchiKey":"UKAUYVFTDYCKQA-VKHMYHEASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HOMOSERINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Isothreonine","L-Homoserine"],"crossReferences":{"Wikipedia":["Homoserine"],"drugbank":["DB04193"],"chEBI":["15699"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1182833","canonicalSmiles":"COc1cc2c(cc1OC)[C@@H](Cc1cc(OC)c(OC)c(OC)c1)[N+](C)(CCCOC(=O)CC/C=C/CCC(=O)OCCC[N+]1(C)CCc3cc(OC)c(OC)cc3[C@H]1Cc1cc(OC)c(OC)c(OC)c1)CC2","inchiKey":"ILVYCEVXHALBSC-OTBYEXOQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MIVACURIUM","yearOfFirstApproval":1992,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["BW B109OU","BW-B109OU","Mivacurium"],"crossReferences":{"PubChem":["144206462","50112723"],"drugbank":["DB01226"],"chEBI":["6958"]},"childChemblIds":["CHEMBL984"],"linkedTargets":{"rows":["ENSG00000170175","ENSG00000138435","ENSG00000135902","ENSG00000108556","ENSG00000196811"],"count":5},"linkedDiseases":{"rows":["HP_0001410"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1992."}
{"id":"CHEMBL1200344","canonicalSmiles":"CCOc1ccc2ccccc2c1C(=O)N[C@@H]1C(=O)N2[C@@H](C(=O)[O-])C(C)(C)S[C@H]12.[Na+]","inchiKey":"AYAPZOUDXCDGIF-FRFVDRIFSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"NAFCILLIN SODIUM","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1443","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Nafcillin Sodium","Nallpen","Unipen"],"synonyms":[],"crossReferences":{"PubChem":["11532894"],"chEBI":["7448"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200376","canonicalSmiles":"C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)c1ccccc1)C(=O)CO","inchiKey":"SOQJPQZCPBDOMF-YCUXZELOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BETAMETHASONE BENZOATE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Uticort"],"synonyms":["Betamethasone benzoate","W 5975","W-5975"],"count":4,"approvedIndications":["HP_0006536","EFO_0009552","HP_0001742","EFO_0005752"],"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["HP_0006536","EFO_0009552","HP_0001742","EFO_0005752","HP_0004798"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and has 4 approved indications."}
{"id":"CHEMBL1200569","canonicalSmiles":"Cn1c(=O)c2c(ncn2C)n(C)c1=O.O=C(O)CC(O)(CC(=O)O)C(=O)O","inchiKey":"RCQXSQPPHJPGOF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CAFFEINE, CITRATED","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL113","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cafcit","Caffeine citrate","Peyona"],"synonyms":["Caffeine citrate","Caffeine mixture with citric acid","Caffeine, citrated"],"crossReferences":{"DailyMed":["caffeine%20citrate"],"PubChem":["144203650","170464929"]},"count":5,"linkedTargets":{"rows":["ENSG00000282608","ENSG00000170425","ENSG00000128271","ENSG00000163485"],"count":4},"linkedDiseases":{"rows":["EFO_0001421","MONDO_0004567","EFO_0003917","HP_0002104","EFO_1001158","EFO_0003843"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1999 and has 5 investigational indications."}
{"id":"CHEMBL1200582","canonicalSmiles":"Cl.NCC(=O)CCC(=O)O","inchiKey":"ZLHFONARZHCSET-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMINOLEVULINIC ACID HYDROCHLORIDE","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL601","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ameluz","Gleolan","Levulan"],"synonyms":[".delta.-aminolevulinic acid hydrochloride","5 ala hcl (trivial name)","Aminolevulinic acid hydrochloride","NPC-07","NSC-18509"],"crossReferences":{"DailyMed":["aminolevulinic%20acid%20hydrochloride"],"PubChem":["144204979","170464700","26748927"]},"count":12,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1999 and has 12 investigational indications."}
{"id":"CHEMBL1200612","canonicalSmiles":"CCCCOc1cc(C(=O)NCCN(CC)CC)c2ccccc2n1.Cl","inchiKey":"IVHBBMHQKZBJEU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIBUCAINE HYDROCHLORIDE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1086","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Heavy solution nupercaine","Nupercainal","Nupercaine"],"synonyms":["Cincaine chloride","Cinchocaine hydrochloride","Dibucaine hydrochloride"],"crossReferences":{"PubChem":["26747981","26747982","50107328","56422129","855998"],"chEBI":["59735"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1200757","canonicalSmiles":"CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@H](CC[C@@]4(C)[C@H]3C[C@H]([N+]3(C)CCCCC3)[C@@H]4OC(C)=O)[C@@]2(C)C[C@@H]1[N+]1(C)CCCCC1.[Br-].[Br-]","inchiKey":"NPIJXCQZLFKBMV-YTGGZNJNSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"PANCURONIUM BROMIDE","yearOfFirstApproval":1972,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL185073","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Mioblock","Pancuronium bromide","Pavulon"],"synonyms":["ORG NA 97","ORG-NA 97","Pancuronium bromide"],"crossReferences":{"DailyMed":["pancuronium%20bromide"],"PubChem":["144205586","50106734"],"chEBI":["7908"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1972."}
{"id":"CHEMBL1200944","canonicalSmiles":"CC1(C)[C@H](C(=O)[O-])N2C(=O)C[C@H]2S1(=O)=O.[Na+]","inchiKey":"NKZMPZCWBSWAOX-IBTYICNHSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"SULBACTAM SODIUM","yearOfFirstApproval":1986,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL403","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["CP-45,899-2","CP-45899-2","Sulbactam sodium","Sulbactam sodium salt"],"crossReferences":{"DailyMed":["sulbactam%20sodium"]},"count":2,"approvedIndications":["EFO_0000544"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1986 and is indicated for infection and has 1 investigational indication."}
{"id":"CHEMBL1201007","canonicalSmiles":"Cl.OCCOCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1","inchiKey":"IPSVAUIEEPSJRZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYDROXYZINE HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL896","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Atarax","Hydroxyzine","Hydroxyzine HCl","Orgatrax"],"synonyms":["Hydroxyzine HCl"],"crossReferences":{"PubChem":["144212880","85273742","855928"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1201020","canonicalSmiles":"CC(C)N(CCC(C(N)=O)(c1ccccc1)c1ccccn1)C(C)C.O=P(O)(O)O","inchiKey":"CGDDQFMPGMYYQP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"DISOPYRAMIDE PHOSPHATE","yearOfFirstApproval":1977,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL517","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dirythmin","Dirythmin-sa","Disopyramide phosphate","Isomide cr","Norpace","Norpace cr","Rythmodan ret"],"synonyms":["Disopyramide phosphate","SC-13957","SC-7031 PHOSPHATE"],"crossReferences":{"DailyMed":["disopyramide%20phosphate"],"PubChem":["50106185","855629"],"chEBI":["4658"]},"count":2,"linkedTargets":{"rows":["ENSG00000185313","ENSG00000153253","ENSG00000183873","ENSG00000136546","ENSG00000144285","ENSG00000169432","ENSG00000168356","ENSG00000007314","ENSG00000136531","ENSG00000196876"],"count":10},"linkedDiseases":{"rows":["EFO_0000275","EFO_0003144"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1977 and has 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201453","drugType":"Protein","blackBoxWarning":false,"name":"ALBUMIN, IODINATED I 131 SERUM","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Albumotope 1-131","Ihsa 1-131","Megatope","Risa-131"],"synonyms":["Albumin iodinated i-131 serum","Albumin, iodinated (131i) human serum","Albumin, iodinated (131i) human serum, injection","Albumin, iodinated i 131 serum","Iodinated (131 i) human serum albumin","Iodinated (131i) human serum albumin","Iodinated (131i) human serum albumin injection","Iodine (131i) human albumin"],"crossReferences":{"DailyMed":["albumin%20iodinated%20i-131%20serum"]},"count":1,"description":"Protein drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL1201459","drugType":"Enzyme","blackBoxWarning":false,"name":"DESOXYRIBONUCLEASE","yearOfFirstApproval":1964,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Deanase"],"synonyms":["Deoxyribonuclease","Desoxyribonuclease"],"description":"Enzyme drug with a maximum clinical trial phase of IV that was first approved in 1964."}
{"id":"CHEMBL1201506","drugType":"Antibody","blackBoxWarning":true,"name":"GEMTUZUMAB OZOGAMICIN","yearOfFirstApproval":2000,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"],"year":2010},"tradeNames":["Mylotarg"],"synonyms":["CDP-771","CMA-676","CMC-676","Gemtuzumab ozogamicin","L01XC05","WAY-CMA-676"],"crossReferences":{"DailyMed":["gemtuzumab%20ozogamicin"],"DrugCentral":["4980"],"Wikipedia":["Gemtuzumab_ozogamicin"]},"count":8,"approvedIndications":["EFO_0000616"],"linkedTargets":{"rows":["ENSG00000105383"],"count":1},"linkedDiseases":{"rows":["EFO_0000198","EFO_0000565","EFO_0000616","EFO_0000095","EFO_0000220","EFO_0000222","EFO_1000309","EFO_0000224"],"count":8},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2000 and is indicated for neoplasm and has 7 investigational indications. It was withdrawn in United States  in 2010. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201734","canonicalSmiles":"Cl.Cn1c(CCCC(=O)O)nc2cc(N(CCCl)CCCl)ccc21","inchiKey":"ZHSKUOZOLHMKEA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENDAMUSTINE HYDROCHLORIDE","yearOfFirstApproval":2008,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL487253","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Belrapzo","Bendamustine hydrochloride","Bendeka","Ribomustine","Treanda"],"synonyms":["Bendamustine hydrochloride","NSC-138783","SDX-105","SYB L-0501","SYBL-0501"],"crossReferences":{"DailyMed":["bendamustine%20hydrochloride"]},"count":15,"approvedIndications":["EFO_0000096","EFO_0000095","EFO_0005952"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2008 and has 3 approved and 12 investigational indications."}
{"id":"CHEMBL1213327","canonicalSmiles":"CC(C)(COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1OP(=O)(O)O)[C@@H](O)C(=O)NCCC(=O)NCCS","inchiKey":"RGJOEKWQDUBAIZ-IBOSZNHHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"COENZYME_A","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CoASH","Coenzyme A","Coenzyme_a"],"crossReferences":{"Wikipedia":["Coenzyme_A"],"drugbank":["DB01992"],"chEBI":["15346"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL1215","canonicalSmiles":"CNC[C@H](O)c1cccc(O)c1","inchiKey":"SONNWYBIRXJNDC-VIFPVBQESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENYLEPHRINE","yearOfFirstApproval":1952,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["AB-101 (PHENYLEPHRINE)","Cyclomydril","Duo-Medihaler","J8.601K","Phenylephrine"],"crossReferences":{"DailyMed":["phenylephrine%20hydrochloride"],"PubChem":["11111644","90340906"],"Wikipedia":["Phenylephrine"],"drugbank":["DB00388"],"chEBI":["8093"]},"childChemblIds":["CHEMBL2062264","CHEMBL1200339"],"count":26,"approvedIndications":["EFO_0005751","EFO_0000319","HP_0001742"],"linkedTargets":{"rows":["ENSG00000171873","ENSG00000170214","ENSG00000120907"],"count":3},"linkedDiseases":{"rows":["EFO_0004610","EFO_0001059","EFO_0006834","EFO_0007486","HP_0012735","EFO_0005252","EFO_0007533","MONDO_0024355","HP_0011950","EFO_0002950","EFO_0003966","EFO_0000178","HP_0100543","EFO_0000544","EFO_0005758","EFO_0003144","EFO_1001898","EFO_0000712","EFO_1000645","EFO_0005751","HP_0011499","EFO_0000616","EFO_0008521","HP_0002140","EFO_0004269","HP_0001919","EFO_0000319","EFO_0001358","HP_0001742","EFO_0003843","EFO_0001073","EFO_0007214","EFO_0000537","EFO_0003885","EFO_0009688","HP_0000138","Orphanet_230","EFO_0007328","EFO_0009523","HP_0031273","EFO_0003833","EFO_1001158","EFO_0000668","EFO_0004264","EFO_0005251","EFO_0003956"],"count":46},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1952 and has 3 approved and 23 investigational indications."}
{"id":"CHEMBL1230270","canonicalSmiles":"CN(C)CCCCSC(=N)N","inchiKey":"UFYJLJINUGVUHO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1230270","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11111760","11113540","124881365","124881367","26751749","50104444"],"drugbank":["DB07106"]},"childChemblIds":["CHEMBL1398213"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1230763","canonicalSmiles":"COC(=O)c1ccc(NC(=O)NC[C@H]2CC[C@@H](C(=O)N3CCC[C@H]3CN)N2)cc1","inchiKey":"USDCNOQKDUFKRD-IKGGRYGDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1230763","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07328"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231399","canonicalSmiles":"O=C1CC(=O)N([C@@H]2O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]2O)C(=O)N1","inchiKey":"AODYJUNLDJOADV-YXZULKJRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1231399","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03668"],"chEBI":["41150"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231533","canonicalSmiles":"O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1","inchiKey":"SRLVNYDXMUGOFI-YWEYNIOJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1231533","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["90341251"],"drugbank":["DB07503"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1233300","canonicalSmiles":"O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1","inchiKey":"ZAVGJDAFCZAWSZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYDROXYFASUDIL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hydroxy-Fasudil"],"crossReferences":{"drugbank":["DB04707"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234151","canonicalSmiles":"CC(C)C[C@H](NC(=O)[C@@H](Cc1cccc2ccccc12)NC(=O)N1CCOCC1)B(O)O","inchiKey":"MQMHIOPMTAJOHV-RTWAWAEBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1234151","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["518751"],"drugbank":["DB04732"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1236882","canonicalSmiles":"CN1CCC(C#N)(NC(=O)[C@H](CC2CCCCC2)NC(=O)N2CCOCC2)CC1","inchiKey":"IRSOCWQJNYLTDD-SFHVURJKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1236882","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08752"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1256575","canonicalSmiles":"CCCCS(=N)(=O)CCC(N)C(=O)O","inchiKey":"KJQFBVYMGADDTQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1256575","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["26747459","50105970","85230938"],"drugbank":["DB12870"],"chEBI":["28714"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1275","canonicalSmiles":"CCCN1C[C@H](CSC)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21.CS(=O)(=O)O","inchiKey":"UWCVGPLTGZWHGS-ZORIOUSZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PERGOLIDE MESYLATE","yearOfFirstApproval":1988,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL531","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"],"classes":["Cardiotoxicity"],"year":2007},"tradeNames":["Celance","Pergolide mesylate","Permax"],"synonyms":["LY-127809","Pergolide mesilate","Pergolide mesylate"],"crossReferences":{"PubChem":["11533039","144204371","170465250","50106872","56422469"],"chEBI":["8021"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1988. It was withdrawn in United States  in 2007 due to Cardiotoxicity."}
{"id":"CHEMBL128","canonicalSmiles":"CNS(=O)(=O)Cc1ccc2[nH]cc(CCN(C)C)c2c1","inchiKey":"KQKPFRSPSRPDEB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SUMATRIPTAN","yearOfFirstApproval":1992,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Imitrex","Sumatriptan","Tosymra"],"synonyms":["N02CC01","Sumatriptan"],"crossReferences":{"DailyMed":["sumatriptan","sumatriptan%20succinate"],"PubChem":["144205081","170465377","49679316"],"Wikipedia":["Sumatriptan"],"drugbank":["DB00669"],"chEBI":["10650"]},"childChemblIds":["CHEMBL1201150"],"count":3,"approvedIndications":["EFO_0003821"],"linkedTargets":{"rows":["ENSG00000135312","ENSG00000179546"],"count":2},"linkedDiseases":{"rows":["EFO_0005296","EFO_0003821","EFO_0005295","EFO_0003843","HP_0002315"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1992 and is indicated for migraine disorder and has 2 investigational indications."}
{"id":"CHEMBL1289601","canonicalSmiles":"COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O","inchiKey":"WOSKHXYHFSIKNG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LENVATINIB","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Kisplyx","Lenvima"],"synonyms":["E-7080","ER-203492-00","Lenvatinib"],"crossReferences":{"DailyMed":["lenvatinib%20mesylate"],"PubChem":["137276042"],"Wikipedia":["Lenvatinib"],"drugbank":["DB09078"],"chEBI":["85994"]},"childChemblIds":["CHEMBL3527309","CHEMBL2105704"],"count":31,"approvedIndications":["EFO_0000616","EFO_0002892","MONDO_0002108","EFO_0000641","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000128052","ENSG00000102755","ENSG00000037280"],"count":3},"linkedDiseases":{"rows":["MONDO_0003060","EFO_0003086","EFO_0000637","EFO_1001901","EFO_0000756","EFO_0000681","EFO_0000571","EFO_1000261","EFO_1000657","MONDO_0007254","EFO_0004230","EFO_0000231","MONDO_0001056","EFO_0000588","EFO_0000182","EFO_0000501","EFO_0008528","EFO_0000326","EFO_0000641","EFO_0002617","EFO_0000616","MONDO_0002108","MONDO_0008170","MONDO_0007576","MONDO_0044915","EFO_0003060","MONDO_0008315","EFO_0005221","EFO_0000311","EFO_1001961","EFO_1000489","EFO_0003841","MONDO_0000544","EFO_0002892","MONDO_0000831","MONDO_0011962","EFO_0001421","EFO_0000574","MONDO_0003219","EFO_0000181"],"count":40},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and has 5 approved and 26 investigational indications."}
{"id":"CHEMBL1326","canonicalSmiles":"CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12.O=P(O)(O)O","inchiKey":"AEUAEICGCMSYCQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLOROQUINE PHOSPHATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL76","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Chloroquine Phosphate"],"synonyms":["Chloroquine"],"crossReferences":{"PubChem":["50125646","50125647","78301"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1330","canonicalSmiles":"CN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](O[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O)C=C[C@H]3[C@H]1C5","inchiKey":"GNJCUHZOSOYIEC-GAROZEBRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MORPHINE GLUCURONIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Morphine 6-Glucuronide(Minor)","Morphine glucuronide"],"crossReferences":{"Wikipedia":["Morphine-6-glucuronide"],"drugbank":["DB06409"],"chEBI":["80581"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1352","canonicalSmiles":"O=[N+]([O-])O","inchiKey":"GRYLNZFGIOXLOG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NITRIC ACID","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nitrate","Nitric acid"],"crossReferences":{"PubChem":["564240"],"Wikipedia":["Nitric_acid"],"chEBI":["48107"]},"count":6,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL1355","canonicalSmiles":"O=C([O-])CC(O)(CC(=O)[O-])C(=O)[O-].[Na+].[Na+].[Na+]","inchiKey":"HRXKRNGNAMMEHJ-UHFFFAOYSA-K","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM CITRATE","yearOfFirstApproval":1983,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Anticoagulant Sodium Citrate","Canesten oasis","Cymalon","Cystemme","Cystocalm","Cystoleve","Isolyte E","Micolette","Micralax","Relaxit","Sod cit","Urisal"],"synonyms":["Anticoagulant sodium citrate","E-331(III)","E331","FEMA NO. 3026","FEMA NO. 3026, ANHYDROUS-","INS NO.331(III)","INS-331(III)","N-1560","Sodium citrate","Sodium citrate dihydrate","Sodium citrate hydrate"],"crossReferences":{"DailyMed":["sodium%20citrate"],"DrugCentral":["4477"],"Wikipedia":["Monosodium_citrate","Trisodium_citrate"],"drugbank":["DB09154"],"chEBI":["53258"]},"count":9,"approvedIndications":["EFO_0003761","EFO_0004272"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1983 and is indicated for anemia (phenotype) and unipolar depression and has 7 investigational indications."}
{"id":"CHEMBL14012","canonicalSmiles":"CC(C)c1ccccc1OCC1=NCCN1","inchiKey":"GFYSWQDCHLWRMQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FENOXAZOLINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fenoxazoline"],"crossReferences":{"drugbank":["DB13736"]},"childChemblIds":["CHEMBL2106595"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL14060","canonicalSmiles":"Oc1ccccc1","inchiKey":"ISWSIDIOOBJBQZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENOL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Chloraseptic","S.b. ward"],"synonyms":["Carbolic acid","ENT-1814","NSC-36808","Phenol","Phenol, liquefied","Salicylic acid related compound c"],"crossReferences":{"PubChem":["144207012","144208837","144210362","170465486","17389767","26753012","26753013"],"Wikipedia":["Phenol"],"drugbank":["DB03255"],"chEBI":["15882"]},"childChemblIds":["CHEMBL2107497"],"count":6,"approvedIndications":["HP_0002619","EFO_0003785"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for varicose veins and allergy and has 4 investigational indications."}
{"id":"CHEMBL14227","canonicalSmiles":"CCCC(=O)O","inchiKey":"FERIUCNNQQJTOY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUTANOIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Butanoic acid"],"crossReferences":{"PubChem":["144209580","144210484"],"Wikipedia":["Butyric_acid"],"drugbank":["DB03568"],"chEBI":["30772"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL142635","canonicalSmiles":"COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1","inchiKey":"HRRBJVNMSRJFHQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NAFTOPIDIL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Naftopidil"],"crossReferences":{"PubChem":["104171197","144203756","170466026","26719853","26751791","49681769","50104483","90340768"],"drugbank":["DB12092"]},"childChemblIds":["CHEMBL1257069","CHEMBL1532139","CHEMBL1593765"],"count":1,"linkedTargets":{"rows":["ENSG00000171873"],"count":1},"linkedDiseases":{"rows":["EFO_0004253","EFO_0000284","EFO_0000536"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL1433361","canonicalSmiles":"CCCCCCCCOc1ccccc1C(=O)Nc1ccc(C(=O)OCC[N+](C)(CC)CC)cc1","inchiKey":"NQHNLNLJPDMBFN-UHFFFAOYSA-O","drugType":"Small molecule","blackBoxWarning":false,"name":"OTILONIUM","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["26756890"],"drugbank":["DB13500"]},"childChemblIds":["CHEMBL2103773"],"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL148","canonicalSmiles":"C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(SCCNC=N)C[C@H]12","inchiKey":"ZSKVGTPCRGIANV-ZXFLCMHBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IMIPENEM","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Imipenem","MK-0787"],"crossReferences":{"DailyMed":["imipenem"],"PubChem":["144204240","170464934","90341794"],"drugbank":["DB01598"],"chEBI":["471744"]},"childChemblIds":["CHEMBL43708"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1985."}
{"id":"CHEMBL1492","canonicalSmiles":"CN1CCC(OC(c2ccccc2)c2ccccc2)CC1","inchiKey":"OWQUZNMMYNAXSL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIPHENYLPYRALINE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Diphenylpyraline"],"crossReferences":{"PubChem":["11112289","50123603","50123604"],"Wikipedia":["Diphenylpyraline"],"drugbank":["DB01146"],"chEBI":["59788"]},"childChemblIds":["CHEMBL1564"],"count":1,"approvedIndications":["EFO_0003785"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_0003785"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982 and is indicated for allergy."}
{"id":"CHEMBL15245","canonicalSmiles":"COC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21","inchiKey":"BLGXFZZNTVWLAY-SCYLSFHTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"YOHIMBINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Yohimbine"],"crossReferences":{"PubChem":["144203570","170465467","46501178","90340710"],"Wikipedia":["Yohimbine"],"drugbank":["DB01392"],"chEBI":["10093"]},"childChemblIds":["CHEMBL537669"],"count":11,"approvedIndications":["EFO_0004234"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for erectile dysfunction and has 10 investigational indications."}
{"id":"CHEMBL152649","canonicalSmiles":"Cc1nc2ccccc2n1Cc1ccc(Cl)cc1","inchiKey":"WNAQOLSMVPFGTE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLORMIDAZOLE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Chlormidazole"],"crossReferences":{"PubChem":["144205352","170466499","29216097","50085890"],"drugbank":["DB13611"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL155103","canonicalSmiles":"CCOC(=O)c1cc2ccc(O)cc2oc1=O","inchiKey":"IETDBZQIWIJQJG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL155103","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02728"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL157101","canonicalSmiles":"CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1","inchiKey":"XMAYWYJOQHXEEK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"KETOCONAZOLE","yearOfFirstApproval":1981,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Daktarin gold","Daktarin intensiv","Dandrazol","Dandrid","Extina","Ketoconazole","Ketopine","Ketosidin","Ketozole","Nizoral","Nizoral a-d","Nizorelle","Panfungol","Xolegel"],"synonyms":["J02AB02","Ketoconazole","NSC-317629","R 41,400","R-41400"],"crossReferences":{"DailyMed":["ketoconazole"],"PubChem":["456469"],"drugbank":["DB01026"],"chEBI":["48339"]},"count":36,"approvedIndications":["EFO_1000764"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1981 and is indicated for seborrheic dermatitis and has 35 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1618102","canonicalSmiles":"CCCC[N+]1(C)[C@H]2C[C@H](OC(=O)[C@H](CO)c3ccccc3)C[C@@H]1[C@H]1O[C@@H]21","inchiKey":"YBCNXCRZPWQOBR-WVHCHWADSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUTYLSCOPOLAMINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Butylscopolamine"],"crossReferences":{"drugbank":["DB09300"]},"childChemblIds":["CHEMBL1256901"],"count":2,"approvedIndications":["EFO_0010282"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for gastrointestinal disease and has 1 investigational indication."}
{"id":"CHEMBL1628161","canonicalSmiles":"C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3[C@@H](OC)C[C@@]21C","inchiKey":"MTMZZIPTQITGCY-OLGWUGKESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MOXESTROL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Metoxiestrol","Moxestrol","R 2858"],"crossReferences":{"drugbank":["DB13418"],"chEBI":["34857"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1707","canonicalSmiles":"CN(C)C(=O)C(CCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1.Cl","inchiKey":"PGYPOBZJRVSMDS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"LOPERAMIDE HYDROCHLORIDE","yearOfFirstApproval":1976,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL841","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Arret","Diah-limit","Diaquitte","Diareze","Diarrhoea relief","Diasorb","Diocalm","Diocaps","Dioraleze","Entrocalm","Gppe pack","Imodium","Imodium Advanced","Imodium a-d","Imodium a-d ez chews","Imodium classic","Imodium ibs relief","Imodium instant melts","Imodium instants","Imodium liquicaps","Lodiar","Loperagen","Loperamide hydrochloride","Norimode","Normaloe"],"synonyms":["Loperamide hydrochloride","NSC-696356","R 18,553","R-18553"],"crossReferences":{"DailyMed":["loperamide%20hydrochloride"],"PubChem":["11533030","26747556","26747557","50106525","50125622","56422888"],"chEBI":["6533"]},"count":1,"approvedIndications":["HP_0002014"],"linkedTargets":{"rows":["ENSG00000112038"],"count":1},"linkedDiseases":{"rows":["HP_0002014","EFO_0009523"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1976 and is indicated for diarrhea. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1738758","canonicalSmiles":"CN1CCN(c2ccc(OC(F)(F)F)c(Nc3ncc4c(n3)-c3c(c(C(N)=O)nn3CCO)CC4)c2)CC1","inchiKey":"QHLVBNKYJGBCQJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ONVANSERTIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NMS-1286937","NMS-P937","Nms-1286937","Onvansertib","PCM-075"],"crossReferences":{"drugbank":["DB15110"]},"childChemblIds":["CHEMBL4298158","CHEMBL1774489"],"count":3,"linkedTargets":{"rows":["ENSG00000166851"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_1001480","EFO_0000222","MONDO_0008315"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1741367","canonicalSmiles":"CCn1cc(C(=O)[O-])c(=O)c2ccc(C)nc21.O.[Na+]","inchiKey":"OWEXQJSSKQXXSX-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1741367","maximumClinicalTrialPhase":0,"parentId":"CHEMBL5","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11113071"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1743081","drugType":"Antibody","blackBoxWarning":false,"name":"TRALOKINUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CAT-354","Tralokinumab"],"count":6,"linkedTargets":{"rows":["ENSG00000169194"],"count":1},"linkedDiseases":{"rows":["EFO_0002618","EFO_0000729","EFO_0004192","EFO_0000270","EFO_0000768","EFO_0000274"],"count":6},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL1888176","canonicalSmiles":"O=C(O[C@@H]1C[C@@H]2CC[C@H](C1)[N+]21CCCC1)C(O)(c1ccccc1)c1ccccc1","inchiKey":"OYYDSUSKLWTMMQ-JKHIJQBDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TROSPIUM","yearOfFirstApproval":2004,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Trospium"],"crossReferences":{"DailyMed":["trospium%20chloride"],"PubChem":["50112692"],"drugbank":["DB00209"]},"childChemblIds":["CHEMBL3084748"],"count":3,"approvedIndications":["HP_0000020","HP_0000103"],"linkedTargets":{"rows":["ENSG00000133019","ENSG00000181072"],"count":2},"linkedDiseases":{"rows":["EFO_0006865","HP_0000020","EFO_1000781","EFO_0000341","EFO_0000692","HP_0000103"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2004 and is indicated for polyuria and urinary incontinence and has 1 investigational indication."}
{"id":"CHEMBL1908365","canonicalSmiles":"OC[C@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O","inchiKey":"GUBGYTABKSRVRQ-QUYVBRFLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MALTOSE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Maltose"],"crossReferences":{"chEBI":["18147"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1922103","canonicalSmiles":"Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12.O=C(O)C(F)(F)F","inchiKey":"FLSBTFJHUWBGJV-RSAXXLAASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1922103","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1922094","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1929396","canonicalSmiles":"Cc1cc2ncc(C(=O)NCC(C)(C)NCC(=O)N3CCC[C@H]3C#N)cn2n1","inchiKey":"LDXYBEHACFJIEL-HNNXBMFYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ANAGLIPTIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Anagliptin","CWP-403","SK-0403","Sk-0403"],"crossReferences":{"drugbank":["DB12417"]},"childChemblIds":["CHEMBL1929387"],"count":1,"linkedTargets":{"rows":["ENSG00000197635"],"count":1},"linkedDiseases":{"rows":["EFO_0001360"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2009089","canonicalSmiles":"O=[Se](O)O","inchiKey":"MCAHWIHFGHIESP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SELENIOUS ACID","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Selenious acid"],"crossReferences":{"DailyMed":["selenious%20acid"],"PubChem":["144207605"],"drugbank":["DB11127"],"chEBI":["26642"]},"childChemblIds":["CHEMBL2028294","CHEMBL112302"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2019."}
{"id":"CHEMBL2028987","canonicalSmiles":"CC(=O)N[C@H](Cc1ccc2ccccc2c1)C(=O)N[C@H](Cc1ccc(Cl)cc1)C(=O)N[C@H](Cc1cccnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(NC(=O)[C@@H]2CC(=O)NC(=O)N2)cc1)C(=O)N[C@H](Cc1ccc(NC(N)=O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O.CC(=O)O","inchiKey":"AUTFSFUMNFDPLH-KYMMNHPFSA-N","drugType":"Protein","blackBoxWarning":false,"name":"DEGARELIX ACETATE","yearOfFirstApproval":2008,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL415606","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Firmagon"],"synonyms":["Degarelix acetate","Degarelix acetate hydrate","FE-200486","FE200486","FE200486 (FREE BASE)"],"crossReferences":{"DailyMed":["degarelix%20acetate"]},"count":2,"approvedIndications":["EFO_0000673","EFO_0001663"],"linkedTargets":{"rows":["ENSG00000109163"],"count":1},"linkedDiseases":{"rows":["EFO_0000673","EFO_0001663"],"count":2},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2008 and is indicated for prostate carcinoma and prostate adenocarcinoma."}
{"id":"CHEMBL205792","canonicalSmiles":"COc1cc(-c2cccc(N)c2)c2oc(NS(=O)(=O)c3cc(Cl)ccc3Cl)nc2c1","inchiKey":"GAYYMURZGLJDCT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL205792","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07270"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2068675","canonicalSmiles":"C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@@H](O)c1ccnc2ccc(OC)cc12.O=C(O)[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@@H]1O","inchiKey":"HASLNODBPLNIIC-DBGYZGBSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2068675","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1294","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["93576694"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2096639","canonicalSmiles":"CC[C@H](C)[C@H](N)C1=N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(=O)[O-])C(=O)N[C@H](C(=O)N[C@H]2CCCCNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CC(=O)[O-])NC(=O)[C@H](Cc3cnc[nH]3)NC(=O)[C@@H](Cc3ccccc3)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](CCCN)NC2=O)[C@@H](C)CC)CS1.[Zn+2]","inchiKey":"UCRLQOPRDMGYOA-DFTDUNEMSA-L","drugType":"Protein","blackBoxWarning":false,"name":"BACITRACIN ZINC","yearOfFirstApproval":1957,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1200558","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ziba-rx"],"synonyms":["Bacitracin zinc"],"crossReferences":{"DailyMed":["bacitracin%20zinc"]},"count":1,"approvedIndications":["MP_0001845"],"description":"Protein drug with a maximum clinical trial phase of IV that was first approved in 1957 and is indicated for inflammation."}
{"id":"CHEMBL2103871","canonicalSmiles":"COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)[O-].O.[Na+]","inchiKey":"WLPXWQKMVACWII-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"ALISERTIB SODIUM","maximumClinicalTrialPhase":0,"parentId":"CHEMBL483158","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Alisertib sodium","MLN8237-004"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2103883","canonicalSmiles":"O=C(Nc1nc(-c2cc(Cl)cs2)c(N2CCN(C3CCCCC3)CC2)s1)c1cnc(N2CCC(C(=O)O)CC2)c(Cl)c1","inchiKey":"OFZJKCQENFPZBH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AVATROMBOPAG","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Avatrombopag","E-5501","E5501","YM-477"],"crossReferences":{"DailyMed":["avatrombopag%20maleate"],"drugbank":["DB11995"]},"childChemblIds":["CHEMBL2105758"],"count":5,"approvedIndications":["MP_0001914"],"linkedTargets":{"rows":["ENSG00000117400"],"count":1},"linkedDiseases":{"rows":["MP_0001914","EFO_0007160","EFO_0001421","MONDO_0002245","HP_0001873"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and is indicated for hemorrhage and has 4 investigational indications."}
{"id":"CHEMBL2104261","canonicalSmiles":"Cc1ccc(/C=C2/C(=O)C3(C)CCC2C3(C)C)cc1","inchiKey":"HEOCBCNFKCOKBX-SDNWHVSQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ENZACAMENE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["50112672"],"drugbank":["DB11219"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2104486","canonicalSmiles":"C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C.[Br-].[Br-]","inchiKey":"HKDOIORVQFUBKO-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"SUXAMETHONIUM BROMIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL703","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Suxamethonium bromide"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2104534","canonicalSmiles":"NC(=O)OCC(O)c1ccccc1","inchiKey":"OCSOHUROTFFTFO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"STYRAMATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Styramate"],"crossReferences":{"drugbank":["DB13357"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2104769","canonicalSmiles":"CCN1CCC[C@H]1CNC(=O)c1c(O)c(Cl)cc(Cl)c1O[11CH3]","inchiKey":"WAOQONBSWFLFPE-TXWZUYSVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RACLOPRIDE C 11","maximumClinicalTrialPhase":1,"parentId":"CHEMBL8809","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Raclopride c 11"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2105248","canonicalSmiles":"O=C([O-])[C@H](O)[C@@H](O)C(=O)O.[K+]","inchiKey":"KYKNRZGSIGMXFH-ZVGUSBNCSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"POTASSIUM BITARTRATE","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Potassium bitartrate","Potassium hydrogen tartrate","Potassium hydrogentartrate"],"crossReferences":{"DailyMed":["potassium%20bitartrate"],"DrugCentral":["4694"],"drugbank":["DB11107"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2020."}
{"id":"CHEMBL2105638","canonicalSmiles":"CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.Nc1nc(-n2cc(C(=O)O)c(=O)c3cc(F)c(N4CC(O)C4)c(Cl)c32)c(F)cc1F","inchiKey":"AHJGUEMIZPMAMR-WZTVWXICSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"DELAFLOXACIN MEGLUMINE","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2105637","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Baxdela"],"synonyms":["ABT-492","Delafloxacin meglumine","RX-3341","WQ-3034","WQ-3034 AND ABT-492"],"crossReferences":{"DailyMed":["delafloxacin%20meglumine"]},"count":1,"approvedIndications":["EFO_0000701"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2017 and is indicated for skin disease. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2105655","canonicalSmiles":"CC(=O)O.CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1","inchiKey":"RVEUYBMXVVDLFO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SOTRASTAURIN ACETATE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL565612","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AEB071","Sotrastaurin acetate"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2105972","canonicalSmiles":"CC[N+](C)(C)CCC(C(N)=O)(c1ccccc1)c1ccccc1.[Br-]","inchiKey":"VTAGVKVPFBOVRM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMBUTONIUM BROMIDE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL2110771","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aludrox sa","Gppe susp"],"synonyms":["Ambutonium bromide"],"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL2106065","canonicalSmiles":"CCN(CC)CCCNCc1cc(Cl)c2cccnc2c1O.Cl","inchiKey":"MHQRIKBJCFNCIH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLAMOXYQUIN HYDROCHLORIDE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL2110791","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Clamoxyl"],"synonyms":["CI-433","CN-17,900-2B","CN-17900-2B","Clamoxyquin hydrochloride","NSC-20246","PAA-3854"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2106195","canonicalSmiles":"Cc1cccc([C@H](C)c2c[nH]cn2)c1C.Cl","inchiKey":"VPNGEIHDPSLNMU-MERQFXBCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXMEDETOMIDINE HYDROCHLORIDE","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL778","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dexmedetomidine hydrochloride","Precedex"],"synonyms":["Dexmedetomidine hydrochloride"],"crossReferences":{"DailyMed":["dexmedetomidine%20hydrochloride"],"chEBI":["31472"]},"count":5,"linkedTargets":{"rows":["ENSG00000274286","ENSG00000184160","ENSG00000150594"],"count":3},"linkedDiseases":{"rows":["EFO_0003777","EFO_0000278","EFO_1001454","EFO_0009267","MONDO_0043510","EFO_0000692","EFO_0003843","EFO_0005411"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1999 and has 5 investigational indications."}
{"id":"CHEMBL2106710","canonicalSmiles":"Cl.Oc1ccc2c(c1)C(Cc1c[nH]cn1)CC2","inchiKey":"OYKZVKWXOWICFI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FADOLMIDINE HYDROCHLORIDE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL2104262","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fadolmidine hydrochloride","MPV-2426","Radolmidine hydrochloride"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2107830","canonicalSmiles":"OC[C@H]1O[C@@H](c2ccc(Cl)c(Cc3ccc(O[C@H]4CCOC4)cc3)c2)[C@H](O)[C@@H](O)[C@@H]1O","inchiKey":"OBWASQILIWPZMG-QZMOQZSNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EMPAGLIFLOZIN","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bi 10773","Jardiance"],"synonyms":["BI 10773","BI-10773","Empagliflozin"],"crossReferences":{"DailyMed":["empagliflozin"],"drugbank":["DB09038"],"chEBI":["82720"]},"count":15,"approvedIndications":["EFO_0001360","EFO_0000400"],"linkedTargets":{"rows":["ENSG00000140675"],"count":1},"linkedDiseases":{"rows":["EFO_0003086","EFO_0003095","EFO_0000401","EFO_0004997","EFO_0000319","EFO_0004194","EFO_0001073","EFO_0000660","EFO_0000537","HP_0012664","EFO_0004593","Orphanet_364","EFO_0003144","EFO_0001359","EFO_0003884","EFO_0002614","HP_0002902","EFO_1001121","EFO_0008583","EFO_0000612","EFO_0001360","EFO_0000400","EFO_1000982"],"count":23},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2014 and is indicated for diabetes mellitus and type ii diabetes mellitus and has 13 investigational indications."}
{"id":"CHEMBL2107842","drugType":"Protein","blackBoxWarning":false,"name":"ALBINTERFERON ALFA-2B","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Albuferon"],"synonyms":["Albinterferon alfa-2b"],"count":3,"linkedTargets":{"rows":["ENSG00000159110","ENSG00000142166"],"count":2},"linkedDiseases":{"rows":["EFO_0004220","EFO_0003047","EFO_0004239"],"count":3},"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2107943","drugType":"Small molecule","blackBoxWarning":false,"name":"POLIDEXIDE SULFATE","yearOfFirstApproval":1974,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United Kingdom"],"year":1975},"tradeNames":[],"synonyms":["Polidexide","Polidexide sulfate"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1974. It was withdrawn in United Kingdom  in 1975."}
{"id":"CHEMBL2108253","drugType":"Antibody","blackBoxWarning":false,"name":"ARCITUMOMAB","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Cea-scan"],"synonyms":["Arcitumomab","IMMU-4"],"crossReferences":{"DrugCentral":["5127"]},"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2108724","drugType":"Protein","blackBoxWarning":true,"name":"SEMAGLUTIDE","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ozempic","Rybelsus"],"synonyms":["NN-9535","NN9535","NNC 0113-0217","NNC-0113-0217","Nn9535","Semaglutide"],"crossReferences":{"DailyMed":["semaglutide"]},"count":7,"approvedIndications":["EFO_0001360","EFO_0000400"],"linkedTargets":{"rows":["ENSG00000112164"],"count":1},"linkedDiseases":{"rows":["EFO_0003095","MONDO_0002009","EFO_0002508","EFO_0001359","EFO_1001249","EFO_0001360","EFO_0001073","EFO_0000400"],"count":8},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and is indicated for diabetes mellitus and type ii diabetes mellitus and has 5 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2109516","drugType":"Antibody","blackBoxWarning":false,"name":"SS1(DSFV)-PE38","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SS1(DSFV)-PE38","Ss1(dsfv)-pe38"],"count":9,"linkedTargets":{"rows":["ENSG00000102854"],"count":1},"linkedDiseases":{"rows":["EFO_0002618","EFO_0000616","MONDO_0002158","EFO_0006859","EFO_0000588","MONDO_0002974","MONDO_0008170","MONDO_0008903","MONDO_0002087"],"count":9},"description":"Antibody drug with a maximum clinical trial phase of I (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL2109604","drugType":"Antibody","blackBoxWarning":false,"name":"MEDI-2338","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MEDI-2338","Medi-2338"],"count":1,"linkedTargets":{"rows":["ENSG00000150782"],"count":1},"linkedDiseases":{"rows":["EFO_0000341"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2110773","canonicalSmiles":"C[N+]1(CC2CC2)[C@H]2C[C@H](OC(=O)[C@H](CO)c3ccccc3)C[C@@H]1[C@H]1O[C@@H]21","inchiKey":"QVVOZYKELHAIPX-WVHCHWADSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CIMETROPIUM","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB09271"]},"childChemblIds":["CHEMBL2105977"],"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL2110774","canonicalSmiles":"CN(C)CCOC(C)(c1ccccc1)c1ccc(Cl)cc1","inchiKey":"KKHPNPMTPORSQE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLORPHENOXAMINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Chlorphenoxamine"],"crossReferences":{"drugbank":["DB09007"]},"childChemblIds":["CHEMBL2105980"],"count":2,"approvedIndications":["HP_0000989","EFO_0003785"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["HP_0000989","EFO_0003785"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for allergy and pruritus."}
{"id":"CHEMBL2110796","canonicalSmiles":"C[N+](C)(C)CCOC(Cc1ccccc1)c1ccccc1","inchiKey":"LBRNZQRZDLLIHL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BIBENZONIUM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB13630"]},"childChemblIds":["CHEMBL2106083"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2139597","canonicalSmiles":"CC[C@@H]1C(=O)OC[C@@H]1CC1=CN=C[NH+]1C.O=[N+]([O-])[O-]","inchiKey":"FQTIRVOROACNDP-GNAZCLTHSA-O","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2139597","maximumClinicalTrialPhase":0,"parentId":"CHEMBL550","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["56422384"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2170804","canonicalSmiles":"CS(=O)(=O)O.OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1","inchiKey":"HBEMHKVWZJTVOC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2170804","maximumClinicalTrialPhase":0,"parentId":"CHEMBL2001019","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL230006","canonicalSmiles":"CC1(C)[C@@H](O)CC[C@@]2(C)[C@H]1CC[C@]1(C)[C@@H]2C(=O)C=C2[C@@H]3C[C@@](C)(C(=O)O)CC[C@]3(C)CC[C@]21C","inchiKey":"MPDGHEJMBKOTSU-YKLVYJNSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ENOXOLONE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Enoxolone","Glycyrrhetic acid","NSC-35347","NSC-35350","Rhetinic acid","Uralenic acid"],"crossReferences":{"PubChem":["104171338","11533025","144204355","144206279","144207997","26754257","29215195","56424132"],"Wikipedia":["Glycyrrhetinic_acid"],"drugbank":["DB13089"],"chEBI":["30853"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL232827","canonicalSmiles":"c1cn(-c2ccc(O[C@H]3CCCN(Cc4ccc5c(c4)OCO5)C3)cc2)cn1","inchiKey":"HHOPJGKEAIIIDF-FQEVSTJZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL232827","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07011"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL23588","canonicalSmiles":"O=C(O)c1ccccc1Nc1cccc(C(F)(F)F)c1","inchiKey":"LPEPZBJOKDYZAD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUFENAMIC ACID","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Arlef","Meralen"],"synonyms":["CI 440","CI-440","CN-27,554","CN-27554","Flufenamic acid","INF-1837","NSC-219007","NSC-82699"],"crossReferences":{"PubChem":["104171306","11112395","124882329","144204003","144212428","170465857","26747013","26751533","26751535","56422408","855855"],"Wikipedia":["Flufenamic_acid"],"drugbank":["DB02266"],"chEBI":["42638"]},"count":1,"approvedIndications":["EFO_0005755"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for rheumatic disease."}
{"id":"CHEMBL24646","canonicalSmiles":"COc1ccc(-c2nc3cc(C4=NNC(=O)CC4C)ccc3[nH]2)cc1","inchiKey":"GLBJJMFZWDBELO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIMOBENDAN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pimobendan","Pimobendane","UDCG-115"],"crossReferences":{"PubChem":["174007050"],"Wikipedia":["Pimobendan"],"drugbank":["DB11450"],"chEBI":["32003"]},"childChemblIds":["CHEMBL2354434"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL250787","canonicalSmiles":"C[C@@H]1c2nc(C(F)(F)F)nn2CCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F","inchiKey":"FDEXEPZGMKFCTG-PSASIEDQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL250787","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07081"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL255465","canonicalSmiles":"NC1=N/C(=C2/CCNC(=O)c3[nH]ccc32)C(=O)N1","inchiKey":"JYRJOQGKGMHTOO-VURMDHGXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEBROMOHYMENIALDISINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(Z)-2-Debromohymenialdisine","Debromohymenialdisine"],"crossReferences":{"drugbank":["DB04367"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL255863","canonicalSmiles":"Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1","inchiKey":"HHZIURLSWUIHRB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"NILOTINIB","yearOfFirstApproval":2007,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tasigna"],"synonyms":["AMN 107","AMN-107","AMN107","Nilotinib"],"crossReferences":{"DailyMed":["nilotinib%20hydrochloride"],"PubChem":["124894351","124894352","99460838"],"Wikipedia":["Nilotinib"],"drugbank":["DB04868"],"chEBI":["52172"]},"childChemblIds":["CHEMBL1201740"],"count":25,"approvedIndications":["EFO_0000616","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000097007"],"count":1},"linkedDiseases":{"rows":["EFO_0001361","EFO_0000693","EFO_0000756","EFO_0000249","MONDO_0007254","MONDO_0021063","MONDO_0003541","MONDO_0000437","EFO_0000565","Orphanet_178","EFO_1000218","EFO_0000339","EFO_0000389","EFO_0000326","EFO_0000717","EFO_0002617","MONDO_0013730","EFO_0000616","EFO_0000220","EFO_0002508","Orphanet_44890","EFO_0000222","EFO_1001106","EFO_1001968","MONDO_0003865","EFO_0000311","MONDO_0002171","Orphanet_399","MONDO_0021637","MONDO_0004643"],"count":30},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2007 and is indicated for neoplasm and cancer and has 23 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL271591","canonicalSmiles":"Nc1nc(OC[C@H]2CCC(=O)N2)c2nc[nH]c2n1","inchiKey":"UYPMMHCTXQIWDX-RXMQYKEDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL271591","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02898"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL27810","canonicalSmiles":"CCN(CC)C(=O)Nc1ccc(OCC(O)CNC(C)(C)C)c(C(C)=O)c1","inchiKey":"JOATXPAWOHTVSZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CELIPROLOL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Celiprolol"],"crossReferences":{"Wikipedia":["Celiprolol"],"drugbank":["DB04846"]},"childChemblIds":["CHEMBL1742424"],"count":1,"approvedIndications":["EFO_0000319"],"linkedTargets":{"rows":["ENSG00000274286","ENSG00000184160","ENSG00000169252","ENSG00000043591","ENSG00000150594"],"count":5},"linkedDiseases":{"rows":["Orphanet_286","EFO_0000341","EFO_0000319"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for cardiovascular disease."}
{"id":"CHEMBL290077","canonicalSmiles":"Nc1nc(F)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O","inchiKey":"HBUBKKRHXORPQB-UUOKFMHZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL290077","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["47193876","50125930"],"drugbank":["DB04441"],"chEBI":["39740"]},"childChemblIds":["CHEMBL1780215"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL290352","canonicalSmiles":"CCSCc1ccc2c(c1)c1c3c(c4c5cc(CSCC)ccc5n5c4c1n2[C@H]1C[C@](O)(C(=O)OC)[C@]5(C)O1)CNC3=O","inchiKey":"SCMLRESZJCKCTC-KMYQRJGFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEP-1347","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CEP-1347","Cep-1347","KT-1575","KT-7515","KT7515"],"count":1,"linkedTargets":{"rows":["ENSG00000139625","ENSG00000130758","ENSG00000006432","ENSG00000073803","ENSG00000173327"],"count":5},"linkedDiseases":{"rows":["EFO_0002508"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL298470","canonicalSmiles":"COc1cc(C)c2c(Oc3cccc(C(F)(F)F)c3)c(OC)cc(NC(C)CCCN)c2n1","inchiKey":"LBHLFPGPEGDCJG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TAFENOQUINE","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["SB-252263-AAB","Tafenoquine","WR 238605"],"crossReferences":{"DailyMed":["tafenoquine%20succinate"],"Wikipedia":["Tafenoquine"],"drugbank":["DB06608"]},"childChemblIds":["CHEMBL2364635"],"count":3,"approvedIndications":["EFO_0001068"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and is indicated for malaria and has 2 investigational indications."}
{"id":"CHEMBL30008","canonicalSmiles":"Fc1ccc(C(c2ccc(F)cc2)N2CCN(C/C=C/c3ccccc3)CC2)cc1","inchiKey":"SMANXXCATUTDDT-QPJJXVBHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUNARIZINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Flunarizine"],"crossReferences":{"PubChem":["104171359","124883266","144204376","170466037","26751607","26751608","50104264","50104265","90341204"],"Wikipedia":["Flunarizine"],"drugbank":["DB04841"]},"childChemblIds":["CHEMBL539027","CHEMBL552659"],"count":2,"approvedIndications":["HP_0002321"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for vertigo and has 1 investigational indication."}
{"id":"CHEMBL3039545","drugType":"Protein","blackBoxWarning":false,"name":"LUSPATERCEPT","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Reblozyl"],"synonyms":["ACE-536","Luspatercept","Luspatercept-aamt"],"crossReferences":{"DailyMed":["luspatercept-aamt"]},"count":8,"approvedIndications":["EFO_0004272"],"linkedTargets":{"rows":["ENSG00000105329","ENSG00000119699","ENSG00000092969"],"count":3},"linkedDiseases":{"rows":["EFO_0000198","EFO_0002430","EFO_0004251","MONDO_0044903","EFO_1001996","EFO_0004272","Orphanet_848","EFO_0002429"],"count":8},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2019 and is indicated for anemia (phenotype) and has 7 investigational indications."}
{"id":"CHEMBL305660","canonicalSmiles":"CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1","inchiKey":"MJJALKDDGIKVBE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EBASTINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Kestine"],"synonyms":["Ebastine","LAS W-090","LAS-W-090","RP 64305","RP-64305"],"crossReferences":{"PubChem":["144205778","170465995","26758025","90340626"],"Wikipedia":["Ebastine"],"drugbank":["DB11742"]},"count":1,"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_0005531","EFO_0000555","EFO_0003785"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL3137337","canonicalSmiles":"CC#CC[C@H](C)[C@H](O)/C=C/[C@@H]1[C@H]2c3cccc(CCCC(=O)[O-])c3O[C@H]2C[C@H]1O.[Na+]","inchiKey":"YTCZZXIRLARSET-ZTWNIFTGSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"ESUBERAPROST SODIUM","maximumClinicalTrialPhase":0,"parentId":"CHEMBL3137314","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["APS-314d","BPS-314d","Esuberaprost sodium"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3183117","canonicalSmiles":"O=C(O)CNC(=O)CNC(=O)CNC(=O)CSC(=O)c1ccccc1","inchiKey":"VDPYMEBVIDZKMD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3183117","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144206816"],"drugbank":["DB14082"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3183654","canonicalSmiles":"Cc1cc(O)c(Cl)cc1C","inchiKey":"PSOJLBXHRBFLLQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3183654","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144212242"],"drugbank":["DB15658"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL325029","canonicalSmiles":"C=CCOC(=O)N[C@@H](Cc1ccc(N(C(=O)C(=O)O)c2ccccc2C(=O)O)cc1)C(=O)NCCCCOc1cccc(O)c1C(=O)OC","inchiKey":"JTJBRKLISQICDU-DEOSSOPVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL325029","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04088"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL326523","canonicalSmiles":"C#CCCCn1c(Cc2cc(OC)c(OC)c(OC)c2Cl)nc2c(N)ncnc21","inchiKey":"WUJFGZAAFADPSF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL326523","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04505"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL326611","canonicalSmiles":"O=C(Nc1ccccc1Oc1ccc(C(=O)O)c(C(=O)O)c1)c1cccc([N+](=O)[O-])c1","inchiKey":"NAQUAVBNIYTIIS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL326611","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04044"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL328560","canonicalSmiles":"NS(=O)(=O)c1ccc(N2CCCCS2(=O)=O)cc1","inchiKey":"HMHVCUVYZFYAJI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULTHIAME","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Conadil","Ospolot","Trolone"],"synonyms":["RIKER 594","RIKER-594","Sulthiame","Sultiame"],"crossReferences":{"PubChem":["170465788"],"Wikipedia":["Sultiame"],"drugbank":["DB08329"],"chEBI":["32171"]},"count":1,"approvedIndications":["EFO_0000474"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for epilepsy."}
{"id":"CHEMBL3301585","drugType":"Antibody","blackBoxWarning":false,"name":"PINATUZUMAB VEDOTIN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ACD-22-VCMMAE","ACD-22VCMMAE","ACD22-VCMMAE","DCDT-2980S","DCDT2980S","FCU-2703","FCU2703","Pinatuzumab vedotin","RG-7593","RO-5541072-000","RO-5541072000","RO5541072-000"],"count":3,"linkedTargets":{"rows":["ENSG00000012124"],"count":1},"linkedDiseases":{"rows":["EFO_0000095","EFO_0000403","MONDO_0018906"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3301668","canonicalSmiles":"CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CCCSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O","inchiKey":"NSTRIRCPWQHTIA-DTRKZRJBSA-N","drugType":"Protein","blackBoxWarning":false,"name":"CARBETOCIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Pabal"],"synonyms":["Carbetocin","LV-101"],"crossReferences":{"drugbank":["DB01282"],"chEBI":["59204"]},"count":1,"linkedTargets":{"rows":["ENSG00000180914"],"count":1},"linkedDiseases":{"rows":["MP_0001914","EFO_0009579","MONDO_0001641","EFO_0002950"],"count":4},"description":"Protein drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL3301800","canonicalSmiles":"CC=CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccc(O)cc3)[C@H]2SC1","inchiKey":"WDLWHQDACQUCJR-PBFPGSCMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFPROZIL","yearOfFirstApproval":1991,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cefzil"],"synonyms":["BMY-28100-03-800","Cefprozil"],"crossReferences":{"DailyMed":["cefprozil"],"drugbank":["DB01150"],"chEBI":["3506"]},"childChemblIds":["CHEMBL3184906"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1991."}
{"id":"CHEMBL333826","canonicalSmiles":"Cc1cc(N)c2ccccc2[n+]1CCCCCCCCCC[n+]1c(C)cc(N)c2ccccc21","inchiKey":"PCSWXVJAIHCTMO-UHFFFAOYSA-P","drugType":"Small molecule","blackBoxWarning":false,"name":"DEQUALINIUM","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Dequalinium"],"crossReferences":{"PubChem":["11111064","11111065","11113637","124879872","225144172","50104538","90340946"],"Wikipedia":["Dequalinium"],"drugbank":["DB04209"],"chEBI":["41872"]},"childChemblIds":["CHEMBL1256847","CHEMBL121663"],"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL343448","canonicalSmiles":"C/C=C1\\NC(=O)[C@H]2CSSCC/C=C/[C@H](CC(=O)N[C@H](C(C)C)C(=O)N2)OC(=O)[C@H](C(C)C)NC1=O","inchiKey":"OHRURASPPZQGQM-GCCNXGTGSA-N","drugType":"Protein","blackBoxWarning":false,"name":"ROMIDEPSIN","yearOfFirstApproval":2009,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Chromadax","Istodax"],"synonyms":["Depsipeptide","FK-228","FK228","FR-901228","FR901228","NSC-630176","Romidepsin"],"crossReferences":{"DailyMed":["romidepsin"],"PubChem":["144206460"],"drugbank":["DB06176"],"chEBI":["61080"]},"count":40,"approvedIndications":["EFO_0000211","EFO_0000616","EFO_0002913","MONDO_0000430"],"linkedTargets":{"rows":["ENSG00000108840","ENSG00000094631","ENSG00000061273","ENSG00000147099","ENSG00000163517","ENSG00000100429","ENSG00000116478","ENSG00000068024","ENSG00000171720","ENSG00000048052","ENSG00000196591"],"count":11},"linkedDiseases":{"rows":["MONDO_0004192","EFO_0000756","EFO_0002913","EFO_1001465","EFO_0000255","EFO_1001469","EFO_0005952","EFO_1000984","MONDO_0020654","EFO_1001951","MONDO_0001187","EFO_0000565","MONDO_0008903","EFO_0000501","EFO_0000641","EFO_0002499","EFO_0000183","EFO_1000785","MONDO_0000430","EFO_0002618","EFO_0000616","MONDO_0019465","EFO_0000503","EFO_0000478","MONDO_0008170","EFO_0000403","EFO_0000180","EFO_0002501","EFO_0000224","MONDO_0008315","EFO_0003060","EFO_0000211","EFO_0000304","EFO_0006861","EFO_0000095","EFO_0005537","EFO_0000764","EFO_0002517","EFO_0000702","EFO_0000574","EFO_1001051","EFO_0001378","MONDO_0018906","MONDO_0024880","EFO_0000569"],"count":45},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2009 and has 4 approved and 36 investigational indications."}
{"id":"CHEMBL351706","canonicalSmiles":"N#Cc1ccc2c(c1)CN(S(=O)(=O)c1cccs1)[C@H](Cc1ccccc1)CN2Cc1c[nH]cn1","inchiKey":"OLCWFLWEHWLBTO-HSZRJFAPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BMS-214662","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-214662","Bms 214662","Bms-214662"],"crossReferences":{"drugbank":["DB12234"]},"count":5,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL3542264","canonicalSmiles":"CN1CCc2nc([14C](=O)N[C@@H]3C[C@@H](C(=O)N(C)C)CC[C@@H]3NC(=O)C(=O)Nc3ccc(Cl)cn3)sc2C1","inchiKey":"HGVDHZBSSITLCT-BGLGCNFOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3542264","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1269025","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3544996","drugType":"Antibody","blackBoxWarning":false,"name":"IDARUCIZUMAB","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Praxbind"],"synonyms":["BI 655075","BI-655075","BI655075","Idarucizumab"],"crossReferences":{"DailyMed":["idarucizumab"],"DrugCentral":["5055"]},"count":1,"approvedIndications":["MP_0001914"],"description":"Antibody drug with a maximum clinical trial phase of IV that was first approved in 2015 and is indicated for hemorrhage."}
{"id":"CHEMBL3545022","drugType":"Small molecule","blackBoxWarning":false,"name":"ULIXERTINIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BVD-ERK","Bvd-523","Ulixertinib","VRT-752271"],"count":4,"linkedTargets":{"rows":["ENSG00000102882","ENSG00000100030"],"count":2},"linkedDiseases":{"rows":["EFO_0000198","EFO_0000616","EFO_0002618","EFO_1000616","EFO_0000222"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL3545032","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-04634817","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pf-04634817"],"count":2,"linkedTargets":{"rows":["ENSG00000160791","ENSG00000121807"],"count":2},"linkedDiseases":{"rows":["HP_0000083","EFO_0000401","EFO_0009321"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3545066","canonicalSmiles":"C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)[C@H](N)Cc2ccccc2)CSSC[C@@H](C(=O)N[C@H](CO)[C@@H](C)O)NC1=O.Cl.Cl","inchiKey":"PPJMKGDKFBCNIY-LODIGNQBSA-N","drugType":"Protein","blackBoxWarning":false,"name":"OCTREOTIDE HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1680","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Octreotide hydrochloride","SMS995-AAA"],"description":"Protein drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545188","canonicalSmiles":"NCCCC[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](c2ccccc2)NC(=O)[C@@H]2C[C@H](OC(=O)NCCN)CN2C(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(OCc3ccccc3)cc2)NC1=O.O=C(O)c1cc2ccccc2c(Cc2c(O)c(C(=O)O)cc3ccccc23)c1O","inchiKey":"HSXBEUMRBMAVDP-NEOZNVFSSA-N","drugType":"Protein","blackBoxWarning":false,"name":"PASIREOTIDE PAMOATE","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL3039583","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Signifor lar","Signifor lar kit"],"synonyms":["Pasireotide pamoate"],"count":1,"approvedIndications":["EFO_1001485"],"linkedTargets":{"rows":["ENSG00000162009","ENSG00000278195","ENSG00000139874","ENSG00000180616"],"count":4},"linkedDiseases":{"rows":["EFO_1001485"],"count":1},"description":"Protein drug with a maximum clinical trial phase of IV that was first approved in 2014 and is indicated for acromegaly."}
{"id":"CHEMBL3545388","canonicalSmiles":"CCN1CCC(c2cc(F)cc(S(C)(=O)=O)c2)CC1","inchiKey":"PHRDGRSMZPOCAB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SERIDOPIDINE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Acr343","Seridopidine"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545397","drugType":"Small molecule","blackBoxWarning":false,"name":"ACALISIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Acalisib","CAL-120","CAL120","GS-9820","GS9820","Gs-9820"],"count":1,"linkedTargets":{"rows":["ENSG00000171608"],"count":1},"linkedDiseases":{"rows":["EFO_0001642"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545404","drugType":"Small molecule","blackBoxWarning":false,"name":"CCX354","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CCX354","CCX354-C","Ccx354","GSK-2941266","GSK2941266"],"count":1,"linkedTargets":{"rows":["ENSG00000163823"],"count":1},"linkedDiseases":{"rows":["EFO_0000685"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL369251","canonicalSmiles":"CC(=N)N1CCC(Oc2ccc3c4ccccc4n(Cc4ccc5ccc(C(=N)N)cc5c4)c3c2)CC1","inchiKey":"DZLGSWPXZYDHBD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL369251","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02112"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3707207","drugType":"Oligosaccharide","blackBoxWarning":false,"name":"PARNAPARIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Parnaparin"],"count":2,"description":"Oligosaccharide drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3707276","drugType":"Protein","blackBoxWarning":false,"name":"VOSORITIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMN 111","BMN-111","Bmn 111","Vosoritide"],"count":2,"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3707294","drugType":"Antibody","blackBoxWarning":false,"name":"DEPATUXIZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ABT-806","Depatuxizumab"],"count":2,"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3707297","drugType":"Antibody","blackBoxWarning":false,"name":"CG250 177LU","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CG250","Cg250 (177lu)","Cg250 177lu"],"count":1,"linkedTargets":{"rows":["ENSG00000107159"],"count":1},"linkedDiseases":{"rows":["EFO_0000681"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL3707354","drugType":"Small molecule","blackBoxWarning":false,"name":"ABT-560","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Abt-560"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3763743","canonicalSmiles":"Oc1ccc(Oc2sc3cc(O)ccc3c2-c2ccc(F)cc2)cc1","inchiKey":"UDBMVVLTKJMPCJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TTC-352","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SHERPA TTC-352","TTC-352","Ttc-352"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3794184","canonicalSmiles":"[2H]C([2H])([2H])OC1=CC(=O)C[C@@H](C)[C@]12Oc1c(Cl)c(OC)cc(OC)c1C2=O","inchiKey":"DDUHZTYCFQRHIY-BCBJJHLGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3794184","maximumClinicalTrialPhase":0,"parentId":"CHEMBL562","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL387675","canonicalSmiles":"CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C","inchiKey":"DOAKLVKFURWEDJ-RWDRXURGSA-N","drugType":"Protein","blackBoxWarning":false,"name":"DAPTOMYCIN","yearOfFirstApproval":2003,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cubicin","Cubicin rf","Daptomycin"],"synonyms":["Daptomycin","LY 146032","LY-146032","LY-164032"],"crossReferences":{"DailyMed":["daptomycin"],"chEBI":["600103"]},"count":16,"approvedIndications":["EFO_0000771","EFO_0000544"],"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2003 and is indicated for infection and bacterial disease and has 14 investigational indications."}
{"id":"CHEMBL3956446","canonicalSmiles":"CCCC[C@]1(CC)CS(=O)(=O)c2ccc(N(C)C)cc2[C@@H](c2cccc(NC(=O)N[C@@H]3O[C@H](COS(=O)(=O)O)[C@@H](O)[C@H](OCc4ccccc4)[C@H]3O)c2)[C@H]1O.N","inchiKey":"JHFURPGPOZEEFG-DXFHJFHKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3956446","maximumClinicalTrialPhase":0,"parentId":"CHEMBL3707222","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3989647","canonicalSmiles":"CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](C(=O)O)c3ccsc3)C(=O)N2[C@H]1C(=O)[O-].O.[Na+]","inchiKey":"BVGLWBKHBMAPKY-QBGWIPKPSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"TICARCILLIN MONOSODIUM","maximumClinicalTrialPhase":3,"parentId":"CHEMBL1449","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ticarcillin monosodium"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL3989978","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"PREXIGEBERSEN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BP-100-1.01/L-Grb2","BP-1001","Prexigebersen"],"count":1,"description":"Oligonucleotide drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3990021","drugType":"Antibody","blackBoxWarning":false,"name":"VADASTUXIMAB TALIRINE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SGN - CD33A","SGN-CD33A","SGNCD33A","Vadastuximab talirine"],"count":3,"description":"Antibody drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3990804","canonicalSmiles":"Cc1oc(-c2ccccc2)nc1CCOc1ccc(CC2SC(=O)NC2=O)c2sccc12","inchiKey":"HAAXAFNSRADSMK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EDAGLITAZONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Edaglitazone"],"crossReferences":{"drugbank":["DB06519"]},"childChemblIds":["CHEMBL3989761"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL402262","canonicalSmiles":"NS(=O)(=O)c1cc([C@@]2(O)NC(=O)c3ccccc32)ccc1Cl","inchiKey":"JIVPVXMEBJLZRO-AWEZNQCLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL402262","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11112206"],"drugbank":["DB08046"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL403989","canonicalSmiles":"Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12","inchiKey":"JMGXJHWTVBGOKG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TG100-801","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TG100-801","Tg100-801"],"crossReferences":{"drugbank":["DB05075"]},"count":3,"linkedTargets":{"rows":["ENSG00000128052","ENSG00000066468","ENSG00000113721","ENSG00000196411","ENSG00000010810","ENSG00000101336","ENSG00000000938","ENSG00000182866","ENSG00000102755","ENSG00000077782","ENSG00000254087","ENSG00000125508","ENSG00000136573","ENSG00000111816","ENSG00000176105","ENSG00000197122"],"count":16},"linkedDiseases":{"rows":["EFO_0009606","EFO_0004683","EFO_0003770"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4068611","canonicalSmiles":"Cn1cc(S(=O)(=O)N2CCC3=Cc4c(cnn4-c4ccc(F)cc4)C[C@]3(C(=O)c3cc(C(F)(F)F)ccn3)C2)cn1","inchiKey":"WANIDIGFXJFFEL-SANMLTNESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RELACORILANT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CORT125134","Cort 125134","Relacorilant"],"crossReferences":{"drugbank":["DB14976"]},"count":8,"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0003099","MONDO_0015686","EFO_0002517","EFO_1000251","MONDO_0008170","EFO_1000796","MONDO_0008315","EFO_1000797"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL4297192","drugType":"Small molecule","blackBoxWarning":false,"name":"SIMETHICONE","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Gas-x","Mylanta gas relief","Mylicon infant's drops","Sentry simethicone","Sentry simethicone emulsion"],"synonyms":["ANTIFOAM A","ANTIFOAM AF","Simethicone"],"crossReferences":{"DailyMed":["simethicone"]},"count":6,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and has 6 investigational indications."}
{"id":"CHEMBL4297210","canonicalSmiles":"CC(C)(O)c1nc2ccc(Cl)cc2cc1N","inchiKey":"GUHFUVLKYSQIOQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"REPROXALAP","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ADX-102","ALD-102","NS2","Reproxalap"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297235","drugType":"Unknown","blackBoxWarning":false,"name":"OMBIPEPIMUT-S","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DSP-7888","Ombipepimut-s"],"count":3,"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297247","drugType":"Gene","blackBoxWarning":false,"name":"BIZALIMOGENE RALAPLASMID","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bizalimogene ralaplasmid","PGX-3002","VGX-3100","pGX3002"],"count":3,"description":"Gene drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297290","canonicalSmiles":"C[C@@H]1CN(Cc2ncccn2)C[C@H]1c1cn2c(C3CCOCC3)ncc2c(=O)[nH]1","inchiKey":"GWGNPYYVGANHRJ-GDBMZVCRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IMR-687","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IMR-687","Imr-687","Tovinontrine"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297378","canonicalSmiles":"CC1=C[C@@H]2CN(C(=O)N2OS(=O)(=O)[O-])[C@@H]1C(N)=O.[Na+]","inchiKey":"WHHNOICWPZIYKI-IBTYICNHSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"DURLOBACTAM SODIUM","maximumClinicalTrialPhase":3,"parentId":"CHEMBL4298137","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Durlobactam sodium","ETX-2514","ETX-2514 SODIUM","ETX2514","ETX2514 sodium","Etx2514"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297612","name":"CHEMBL4297612","tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB14903"]}}
{"id":"CHEMBL4297645","canonicalSmiles":"CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)NCCCO/N=C(\\C(=O)N[C@@H]4C(=O)N5C(C(=O)[O-])=C(C[n+]6ccccc6)CS[C@H]45)c4nc(N)sc4Cl)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(N)[C@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@H]1O","inchiKey":"OGUAFUAJSPORAH-KHCCTVBNSA-N","drugType":"Unknown","blackBoxWarning":false,"name":"CEFILAVANCIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cefilavancin","TD-1792","Td-1792"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297962","drugType":"Unknown","blackBoxWarning":false,"name":"GNKG-168","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CPG-685","GNKG168","Gnkg-168","Gnkg168"],"count":3,"description":"Unknown drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4298085","drugType":"Antibody","blackBoxWarning":false,"name":"FIANLIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fianlimab","REGN-3767","REGN3767","Regn3767"],"count":3,"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4303313","canonicalSmiles":"Cl.O.O.O=C1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3CC2CC2)[C@H]1O5","inchiKey":"RMRRPHDKLROLJJ-VNANXUGNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL4303313","maximumClinicalTrialPhase":0,"parentId":"CHEMBL19019","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4303525","canonicalSmiles":"CC1(C)CC[C@]2(NC(=O)C(C)(F)F)CC[C@]3(C)[C@H](C(=O)C=C4[C@@]3(C)CC[C@H]3C(C)(C)C(=O)C(C#N)=C[C@]43C)[C@@H]2C1","inchiKey":"RJCWBNBKOKFWNY-IDPLTSGASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OMAVELOXOLONE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Omaveloxolone","RTA 408","RTA-408"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL449062","canonicalSmiles":"C=C(C)[C@H]1CC=C(C)CC1","inchiKey":"XMGQYMWWDOXHJM-JTQLQIEISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"D-LIMONENE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["D-Limonene","D-limonene"],"crossReferences":{"PubChem":["144207598"],"Wikipedia":["Limonene"],"drugbank":["DB08921"],"chEBI":["15382"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4594288","canonicalSmiles":"CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)[C@@H]1c1ccccc1Cl.O=C(O)/C=C\\C(=O)O","inchiKey":"TZNOWAJJWCGILX-HNUXRKMMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEVAMLODIPINE MALEATE","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2111097","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Conjupri"],"synonyms":["Levamlodipine maleate"],"crossReferences":{"DailyMed":["levamlodipine%20maleate"]},"count":1,"approvedIndications":["EFO_0000537"],"linkedTargets":{"rows":["ENSG00000157388","ENSG00000081248","ENSG00000151067","ENSG00000102001"],"count":4},"linkedDiseases":{"rows":["EFO_0000537"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2019 and is indicated for hypertension."}
{"id":"CHEMBL4594381","canonicalSmiles":"[2H]C1([2H])C([C@@H](CC#N)n2cc(-c3ncnc4[nH]ccc34)cn2)C([2H])([2H])C([2H])([2H])C1([2H])[2H]","inchiKey":"HFNKQEVNSGCOJV-FBXGHSCESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEURUXOLITINIB","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1789941","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["C-21543","CTP-543","D8-ruxolitinib","Deuruxolitinib"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4594505","drugType":"Antibody","blackBoxWarning":false,"name":"TECLISTAMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Jnj 64007957","Teclistamab"],"count":1,"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594537","drugType":"Unknown","blackBoxWarning":false,"name":"DNL-310","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DNL-310","DNL310","Dnl-310","Dnl310"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL463763","canonicalSmiles":"CC(C)[C@]12O[C@H]1[C@@H]1O[C@@]13[C@@]1(C)CCC4=C(COC4=O)[C@@H]1C[C@@H]1O[C@@]13[C@@H]2O","inchiKey":"DFBIRQPKNDILPW-CIVMWXNOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIPTOLIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-163062","Triptolide"],"crossReferences":{"PubChem":["26719814","26756783","26756784","438041","49681800"],"drugbank":["DB12025"],"chEBI":["9747"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL473922","canonicalSmiles":"Nc1nc2c([C@@H]3N[C@H](CO)[C@@H](O)[C@H]3O)c[nH]c2c(=O)[nH]1","inchiKey":"KBIDJCVAURJXFG-PVEDRDFWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL473922","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02230"],"chEBI":["43467"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL497689","canonicalSmiles":"Nc1ccc(S(=O)(=O)NC(=O)NCCS)cc1","inchiKey":"LHVDNDIAMJOEKH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL497689","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08484"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL507870","canonicalSmiles":"CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O","inchiKey":"ONUMZHGUFYIKPM-MXNFEBESSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TELAVANCIN","yearOfFirstApproval":2009,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Telavancin"],"crossReferences":{"DailyMed":["telavancin%20hydrochloride"],"drugbank":["DB06402"],"chEBI":["71229"]},"childChemblIds":["CHEMBL3301680"],"count":7,"approvedIndications":["EFO_0000771"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2009 and is indicated for bacterial disease and has 6 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL511099","canonicalSmiles":"Cc1ccc(C23CNCC2C3)cc1","inchiKey":"OFYVIGTWSQPCLF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BICIFADINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bicifadine"],"crossReferences":{"drugbank":["DB04889"]},"childChemblIds":["CHEMBL544862"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL518520","canonicalSmiles":"Cc1nnc(C(=O)NC(C)(C)c2nc(C(=O)NCc3ccc(F)cc3)c([O-])c(=O)n2C)o1.[K+]","inchiKey":"IFUKBHBISRAZTF-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"RALTEGRAVIR POTASSIUM","yearOfFirstApproval":2007,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL254316","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Isentress","Isentress hd"],"synonyms":["MK-0518","MK-0518 POTASSIUM","MK0518 POTASSIUM","Raltegravir monopotassium salt","Raltegravir potassium"],"crossReferences":{"DailyMed":["raltegravir%20potassium"]},"count":1,"approvedIndications":["EFO_0000764"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2007 and is indicated for hiv infection."}
{"id":"CHEMBL538867","canonicalSmiles":"CC1=C2C[C@H]3[C@@H](CC[C@@H]4C[C@H](NS(C)(=O)=O)CC[C@]34C)[C@@H]2CC[C@@]2(C1)O[C@@H]1C[C@H](C)CN[C@H]1[C@H]2C","inchiKey":"HZLFFNCLTRVYJG-WWGOJCOQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PATIDEGIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["FIN-5","IP-9","IP9 FREE BASE","IPI 926","IPI-926","IPI-926 FREE BASE","Ipi-926","Patidegib","Saridegib"],"crossReferences":{"Wikipedia":["IPI-926"],"drugbank":["DB12655"]},"childChemblIds":["CHEMBL2105764"],"count":5,"linkedTargets":{"rows":["ENSG00000128602"],"count":1},"linkedDiseases":{"rows":["EFO_0002618","EFO_0000616","Orphanet_377","EFO_0004193","EFO_0000333"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL545608","canonicalSmiles":"Cl.O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1","inchiKey":"JMRYYMBDXNZQMH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HALOPERIDOL HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL54","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["26719726"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL54918","canonicalSmiles":"O=c1[nH]c(=O)n([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)cc1F","inchiKey":"FHIDNBAQOFJWCA-UAKXSSHOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"5-Fluorouridine","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["5-Fluorouridine"],"crossReferences":{"PubChem":["124892084","26754269"],"drugbank":["DB01629"],"chEBI":["40154"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL551466","canonicalSmiles":"O=C(O[C@H]1C[N+]2(CCCOc3ccccc3)CCC1CC2)C(O)(c1cccs1)c1cccs1.[Br-]","inchiKey":"XLAKJQPTOJHYDR-QTQXQZBYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"ACLIDINIUM BROMIDE","yearOfFirstApproval":2012,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1194325","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Eklira","Tudorza pressair"],"synonyms":["14115700","Aclidinium bromide","LAS 34273","LAS 34273 MICRONIZED","LAS W-330","LAS-34273","LAS-34273 MICRONIZED","LAS-W-330"],"crossReferences":{"DailyMed":["aclidinium%20bromide"],"Wikipedia":["Aclidinium_bromide"],"chEBI":["65344"]},"count":6,"approvedIndications":["HP_0006536","EFO_0000270","EFO_0000464","EFO_0006505","EFO_0000341"],"linkedTargets":{"rows":["ENSG00000133019"],"count":1},"linkedDiseases":{"rows":["HP_0006536","EFO_0000270","EFO_0000464","EFO_0006505","EFO_0003768","EFO_0000341"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2012 and has 5 approved and 1 investigational indication."}
{"id":"CHEMBL564085","canonicalSmiles":"CO[C@H]1C[C@H](O[C@@H]2[C@@H](C)C(=O)O[C@H](C)[C@H](C)[C@H](OC(C)=O)[C@@H](C)C(=O)[C@]3(CO3)C[C@H](C)[C@H](O[C@@H]3O[C@H](C)C[C@H](N(C)C)[C@H]3OC(C)=O)[C@H]2C)O[C@@H](C)[C@@H]1OC(C)=O","inchiKey":"LQCLVBQBTUVCEQ-QTFUVMRISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TROLEANDOMYCIN","yearOfFirstApproval":1969,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Acetyloleandomycin","NSC-108166","Triacetyloleandomycin","Troleandomycin"],"crossReferences":{"Wikipedia":["Troleandomycin"],"drugbank":["DB13179"],"chEBI":["45735"]},"count":2,"approvedIndications":["EFO_0000771"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1969 and is indicated for bacterial disease and has 1 investigational indication."}
{"id":"CHEMBL568150","canonicalSmiles":"O=C1NC(=O)/C(=C/c2ccc3nccnc3c2)S1","inchiKey":"SQWZFLMPDUSYGV-POHAHGRESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AS-605240","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AS-605240"],"crossReferences":{"PubChem":["90341202"],"drugbank":["DB04769"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL58711","canonicalSmiles":"CC(C)=CCN1Cc2c(Cl)ccc3[nH]c(=S)n(c23)C[C@@H]1C","inchiKey":"ZNFFMCYSMBXZQU-NSHDSACASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TIVIRAPINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["R-87027","Tivirapine"],"crossReferences":{"drugbank":["DB08600"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL63","canonicalSmiles":"COc1ccc(C2CNC(=O)C2)cc1OC1CCCC1","inchiKey":"HJORMJIFDVBMOB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ROLIPRAM","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Rolipram","SB-95952","ZK 62 711","ZK-62711","ZK-62771"],"crossReferences":{"PubChem":["144204223","170465962","26719663","26719664","26752319","26752320","50105263","56422401","85231212","855869","90341367"],"Wikipedia":["Rolipram"],"drugbank":["DB01954"],"chEBI":["104872"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL6318","canonicalSmiles":"CC/C(=C(\\c1ccc(I)cc1)c1ccc(OCCN2CCCC2)cc1)c1ccccc1","inchiKey":"JJKOTMDDZAJTGQ-DQSJHHFOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IDOXIFENE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CB 7432","CB-7432","Idoxifene","SB-223030"],"crossReferences":{"Wikipedia":["Idoxifene"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL65230","canonicalSmiles":"C=CCN(C)Cc1ccc(-c2ccc(C(=O)c3ccc(Br)cc3)cc2)cc1","inchiKey":"YATCZCSDJCQNAL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL65230","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03234"]},"childChemblIds":["CHEMBL481608"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL713","canonicalSmiles":"C=C1[C@@H](n2cnc3c(=O)[nH]c(N)nc32)C[C@H](O)[C@H]1CO","inchiKey":"QDGZDCVAUDNJFG-FXQIFTODSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ENTECAVIR","yearOfFirstApproval":2005,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Baraclude","Entecavir"],"synonyms":["BMS-200475-01","Baraclude","Entecavir","Entecavir hydrate","Entecavir monohydrate","SQ-34676","SQ34676"],"crossReferences":{"DailyMed":["entecavir"],"PubChem":["144205745"],"Wikipedia":["Entecavir"],"drugbank":["DB00442"],"chEBI":["473990"]},"count":10,"approvedIndications":["EFO_0004197","EFO_0000763","EFO_0004239"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2005 and has 3 approved and 7 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL83668","canonicalSmiles":"Cc1cccc(N(C)C(=S)Oc2ccc3ccccc3c2)c1","inchiKey":"FUSNMLFNXJSCDI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TOLNAFTATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aftate","Dr. scholl's athlete's foot spray","Mycil","Timoped","Tinactin","Tinaderm","Tinaderm plus","Tineafax","Tritin"],"synonyms":["NSC-233648","SCH 10144","SCH-10144","Tolnaftate"],"crossReferences":{"PubChem":["11112516","124882425","144204072","144211680","170465508","174007421","26747038","56422400","855906"],"Wikipedia":["Tolnaftate"],"drugbank":["DB00525"],"chEBI":["9620"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL9194","canonicalSmiles":"CCCCN(CCCC)C(=O)CN1C[C@H](c2ccc3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1c1ccc(OC)cc1","inchiKey":"MOTJMGVDPWRKOC-QPVYNBJUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ATRASENTAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["A-127722","Atrasentan"],"crossReferences":{"Wikipedia":["Atrasentan"],"drugbank":["DB06199"]},"childChemblIds":["CHEMBL2106068"],"count":3,"linkedTargets":{"rows":["ENSG00000151617"],"count":1},"linkedDiseases":{"rows":["MONDO_0002158","EFO_0000401","MONDO_0008170","EFO_0000673","MONDO_0002367","EFO_1001461","EFO_0004194","MONDO_0002087","MONDO_0024880","MONDO_0008315","EFO_1000158"],"count":11},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL932","canonicalSmiles":"OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1","inchiKey":"IZEKFCXSFNUWAM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIPYRIDAMOLE","yearOfFirstApproval":1961,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Attia","Cerebrovase 100","Cerebrovase 25","Dipyridamole","Iv persantine","Modaplate","Ofcram pr","Persantin","Persantin ret","Persantine","Pyridantin","Vasyrol"],"synonyms":["B01AC07","Dipyridamole","NSC-515776","RA-8"],"crossReferences":{"DailyMed":["dipyridamole"],"PubChem":["104171148","11111116","11111117","11113358","124879978","124879980","124879984","144203684","170464694","26747068","26751580","26751581","489152","50104213","50104215","56423153","85231021","855977","90340971"],"Wikipedia":["Dipyridamole"],"drugbank":["DB00975"],"chEBI":["4653"]},"count":13,"approvedIndications":["EFO_0000712","HP_0004419"],"linkedTargets":{"rows":["ENSG00000185527","ENSG00000139053","ENSG00000152270","ENSG00000112759","ENSG00000105650","ENSG00000112541","ENSG00000132915","ENSG00000154678","ENSG00000172572","ENSG00000160191","ENSG00000123360","ENSG00000171408","ENSG00000205268","ENSG00000115252","ENSG00000073417","ENSG00000133256","ENSG00000065989","ENSG00000095464","ENSG00000113448","ENSG00000186642","ENSG00000113231","ENSG00000156973","ENSG00000138735","ENSG00000184588"],"count":24},"linkedDiseases":{"rows":["EFO_0002618","EFO_0000685","EFO_0003777","Orphanet_232","EFO_0002687","MONDO_0008170","EFO_0001645","EFO_0002615","EFO_0000537","EFO_0003913","EFO_0000289","MONDO_0100096","EFO_1001375","EFO_1002000","EFO_0000764","EFO_0000712","HP_0004419","EFO_1000059","EFO_0000400"],"count":19},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1961 and is indicated for stroke and recurrent thrombophlebitis and has 11 investigational indications."}
{"id":"CHEMBL954","canonicalSmiles":"CCN(CC)CCOc1ccc(/C(=C(/Cl)c2ccccc2)c2ccccc2)cc1","inchiKey":"GKIRPKYJQBWNGO-OCEACIFDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ENCLOMIPHENE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cisclomiphene","Clomiphene trans-form","Enclomifene","Enclomiphene","ISOMER B","ISOMER-B","Isomer B","Milophene","RMI 16,289","RMI-16289","Serophene"],"crossReferences":{"PubChem":["50085975"],"drugbank":["DB06735"]},"childChemblIds":["CHEMBL1200667"],"count":2,"linkedTargets":{"rows":["ENSG00000091831"],"count":1},"linkedDiseases":{"rows":["MONDO_0002146","EFO_0000545","EFO_0001073","EFO_0000660","MONDO_0018555"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
